NEW YORK, Oct. 6, 2026 /PRNewswire/ — CoreAge Rx, a telehealth company specializing in weight management, today announced lower prices for its GLP-1 program. Compounded semaglutide now starts at $79 per month and compounded tirzepatide at $129 per month when paid annually, down from $99 and $149 announced in January.

The new rates keep the flat-rate structure CoreAge Rx introduced earlier this year. One annual payment covers the provider consultation, medication at every dose level, and overnight cold shipping, with no membership fees.

“When we launched flat-rate pricing, our goal was to take the guesswork out of what weight management treatment costs,” said Ella Jones, spokesperson for CoreAge Rx. “Now we’re taking the next step and lowering the price itself. Patients still pay one rate whether they’re on a starting dose or a maintenance dose, and that rate is now $20 a month lower.”

Patients begin with a free online consultation. A U.S.-licensed provider reviews each case and, if treatment is appropriate, issues a prescription that is filled by a state board-regulated 503A compounding pharmacy.

Medication typically arrives within three to five business days after approval with fast, reliable cold shipping. CoreAge Rx also provides dedicated customer support, with a responsive team available to quickly answer questions and assist patients throughout treatment.

The program offers two options. Semaglutide is a GLP-1 receptor agonist, while tirzepatide acts on both GLP-1 and GIP receptors. A provider helps each patient determine which option, if either, is appropriate based on their health history and treatment goals.

“Cost is one of the biggest reasons people delay or stop weight management care,” Jones added. “Lower, predictable pricing and a fully online process make it easier to start treatment and stay with it.”

For more information or to start a free online consultation, visit https://www.coreagerx.com/.

About CoreAge Rx

CoreAge Rx is a telehealth company specializing in weight management. The company connects patients with U.S.-licensed healthcare providers online and facilitates access to prescribed medications through state board-regulated 503A compounding pharmacies, with transparent flat-rate pricing and no membership fees.

Important information

Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness or quality. Prescriptions are issued only when a licensed provider determines treatment is medically appropriate. Individual results vary. GLP-1 medications can cause side effects, including nausea, vomiting and diarrhea, and are not appropriate for everyone. Pricing reflects annual prepayment; monthly plan pricing may differ.

View original content:https://www.prnewswire.com/news-releases/coreage-rx-cuts-glp-1-prices-to-as-low-as-79-a-month-302899825.html

SOURCE CoreAge Rx